SCHEMBL88608

SCHEMBL88608

c1cnc2cnncc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
NPC1 O15118 5/20 0.47
RAB9A P51151 2/20 0.46
POLB P06746 1/20 0.46
CYP3A4 P08684 2/20 0.45
KDM4E B2RXH2 3/20 0.44
MAPT P10636 3/20 0.44
HTT P42858 3/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 2/20 0.44
HSP90AA1 P07900 2/20 0.44
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GMNN O75496 1/20 0.44
MMP2 P08253 1/20 0.44
CYP2D6 P10635 1/20 0.44
MMP9 P14780 1/20 0.44
ALOX15 P16050 1/20 0.44
NFKB1 P19838 1/20 0.44
MMP8 P22894 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30373705 1.00 ALDH1A1 (0.54) ALDH1A1NPC1RAB9APOLBCYP3A4
SCHEMBL29683629 1.00 ALDH1A1 (0.54) ALDH1A1NPC1RAB9APOLBCYP3A4
Phthalazine SCHEMBL2692127 0.83 ALDH1A1 (0.65) ALDH1A1NPC1RAB9APOLBCYP3A4
Phthalazine SCHEMBL5693003 0.81 ALDH1A1 (0.77) ALDH1A1NPC1RAB9APOLBCYP3A4
Phthalazine SCHEMBL11491846 0.76 ALDH1A1 (0.56) ALDH1A1NPC1RAB9APOLBCYP3A4
Phthalazine SCHEMBL1924788 0.75 ALDH1A1 (0.54) ALDH1A1NPC1RAB9APOLBCYP3A4
Quinoline SCHEMBL27818244 0.74 ALDH1A1 (0.94) ALDH1A1NPC1RAB9APOLBCYP3A4
Phthalazine SCHEMBL5788117 0.73 ALDH1A1 (0.46) ALDH1A1NPC1CYP3A4KDM4EMAPT
SCHEMBL89126 0.73 ALDH1A1 (0.58) ALDH1A1NPC1RAB9APOLBCYP3A4
SCHEMBL139749 0.73 ALDH1A1 (0.58) ALDH1A1NPC1RAB9APOLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6140033-A SUPPORT WITH SILVER HALIDE EMULSIONS WITH COUPLERS EASTMAN KODAK COMPANY (US) 2000-10-31 US claimed
EP-1014185-A1 Photographic element, pyrazolazole coupler, method for it's preparation and an azomethine dye EASTMAN KODAK COMPANY (US) 2000-06-28 EP claimed
EP-0145337-B1 ELECTROCHROMIC DEVICES CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1990-08-08 EP claimed
EP-0096723-B1 BATTERIES FABRICATED WITH ELECTROACTIVE POLYMERS CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1988-08-10 EP claimed
US-4613211-A REVERSE COLOR CHANGING POLYMER FILM AS DISPLAY ELECTRODE CHEVRON RESEARCH COMPANY (US) 1986-09-23 US claimed
US-4579679-A Electroactive polymers CHEVRON RESEARCH COMPANY (US) 1986-04-01 US claimed
EP-0145337-A2 Electrochromic devices CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1985-06-19 EP claimed
EP-0096723-A1 BATTERIES FABRICATED WITH ELECTROACTIVE POLYMERS. CHEVRON RES (US) 1983-12-28 EP claimed
WO-1983002368-A1 BATTERIES FABRICATED WITH ELECTROACTIVE POLYMERS CHEVRON RES (US) 1983-07-07 WO claimed
US-12565613-B2 Quantum dots with donor-acceptor ligands SHOEI CHEMICAL INC. (JP) 2026-03-03 US disclosed
US-12012467-B2 Small molecule DCN1 inhibitors and therapeutic methods using the same REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-06-18 US disclosed
JP-2024010022-A BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-b]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-d]PYRIDAZINE AND PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG CANCER, PANCREATIC CANCER OR COLON CANCER アムジエン・インコーポレーテツド 2024-01-23 JP disclosed
EP-4289813-A2 INTERMEDIATES TO OBTAIN SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION Global Blood Therapeutics, Inc. (US) 2023-12-13 EP disclosed
US-20230255963-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION GLOBAL BLOOD THERAPEUTICS INC (US) 2023-08-17 US disclosed
US-4519937-A DOPED UNITS OF A FUSED NITROGEN-CONTAINING UNSATURATED HETEROCYCLIC RING CHEVRON RESEARCH COMPANY (US) 1985-05-28 US disclosed
US-4519938-A TRACTABLE, DOPED HETEROCYCLIC RINGS CHEVRON RESEARCH COMPANY (US) 1985-05-28 US disclosed
EP-0126064-A1 ELECTROACTIVE POLYMERS CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1984-11-28 EP disclosed
WO-1984002030-A1 ELECTROACTIVE POLYMERS CHEVRON RES (US) 1984-05-24 WO disclosed
EP-0096723-A1 BATTERIES FABRICATED WITH ELECTROACTIVE POLYMERS. CHEVRON RES (US) 1983-12-28 EP disclosed
WO-1983002368-A1 BATTERIES FABRICATED WITH ELECTROACTIVE POLYMERS CHEVRON RES (US) 1983-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565613-B2 Quantum dots with donor-acceptor ligands HCCS, FDPS, FTH1 ALDH1A1 125/4885NPC1 169/4885RAB9A 1423/4885
US-20230255963-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION HBB, HBG2, MB ALDH1A1 216/4885NPC1 4836/4885RAB9A 4560/4885
US-12012467-B2 Small molecule DCN1 inhibitors and therapeutic methods using the same DCUN1D2, CLN6, CAPNS1 ALDH1A1 2290/4885NPC1 1158/4885RAB9A 1389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.